# Mylan Inc. clinical trials: 44 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 44 trials with Mylan Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Mylan Inc.: 44 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/mylan-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 44
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 44, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| December 15, 2021 | NCT05158972 | Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients | Mylan Inc. | Observational | Completed | Allergic Rhinitis | 924 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05158972) |
| September 21, 2021 | NCT05051527 | Study to Evaluate the Effectiveness of Legalon® | Mylan Inc. | Observational | Completed | Non-alcoholic Fatty Liver Disease (NAFLD) | 362 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05051527) |
| September 1, 2021 | NCT05030025 | Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) | Mylan Inc. | Early phase 1 | Completed | HIV-1-infection | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05030025) |
| August 11, 2021 | NCT05000541 | Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical | Mylan Inc. | Observational | Completed | Hypercholesterolemia | 259 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05000541) |
| July 26, 2021 | NCT04976868 | Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis | Mylan Inc. | Observational | Completed | Atopic Dermatitis | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04976868) |
| October 1, 2020 | NCT04571515 | Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain | Mylan Inc. | Phase 2 | Completed | Pain, Postoperative Pain, Pain, Acute | 114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04571515) |
| November 30, 2018 | NCT03760068 | Mylan Insulin Aspart Study | Mylan Inc. | Phase 3 | Completed | Diabetes Mellitus, Type 1 | 478 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03760068) |
| June 29, 2018 | NCT03573817 | A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD | Mylan Inc. | Phase 3 | Completed | Chronic Obstructive Pulmonary Disease (COPD) | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03573817) |
| April 18, 2018 | NCT03502070 | Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules | Mylan Inc. | Phase 4 | Completed | Cystic Fibrosis | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03502070) |
| December 18, 2017 | NCT03376789 | Mylan Insulin Glargine Study | Mylan Inc. | Phase 3 | Completed | Diabetes Mellitus, Type 1 | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03376789) |
| April 26, 2017 | NCT03129321 | Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis | Mylan Inc. | Phase 3 | Completed | Tinea Pedis | 876 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03129321) |
| April 11, 2017 | NCT03107611 | Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis | Mylan Inc. | Phase 3 | Completed | Atopic Dermatitis | 654 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03107611) |
| March 29, 2017 | NCT03095456 | Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD | Mylan Inc. | Phase 3 | Completed | Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate (PIFR) | 207 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03095456) |
| February 24, 2017 | NCT03064113 | Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Mylan Inc. | Phase 2 | Completed | Chronic Obstructive Pulmonary Disease, COPD | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03064113) |
| October 3, 2016 | NCT02921763 | A Survey on Efficacy and Safety in Patients With Endometriosis | Mylan Inc. | Observational | Completed | Endometriosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02921763) |
| June 30, 2016 | NCT02820311 | Thorough QT (TQT) Study of TD-4208 in Healthy Subjects | Mylan Inc. | Phase 1 | Completed | Cardiac Repolarization in Healthy Subjects | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02820311) |
| May 13, 2016 | NCT02772159 | TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects | Mylan Inc. | Phase 1 | Completed | Chronic Obstructive Pulmonary Disease (COPD) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02772159) |
| March 21, 2016 | NCT02714322 | MYL-1401A Efficacy and Safety Comparability Study to Humira® | Mylan Inc. | Phase 3 | Completed | Psoriasis, Arthritis, Psoriatic | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02714322) |
| January 28, 2016 | NCT02666430 | Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients | Mylan Inc. | Phase 3 | Completed | Type 1 Diabetes Mellitus | 127 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02666430) |
| October 21, 2015 | NCT02581592 | Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment | Mylan Inc. | Phase 1 | Completed | Hepatic Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02581592) |
| October 19, 2015 | NCT02579122 | REVIparin-BRIDging-in a General Practice Setting in GErmany | Mylan Inc. | Observational | Terminated | Thromboembolism | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02579122) |
| October 16, 2015 | NCT02578082 | Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment | Mylan Inc. | Phase 1 | Completed | Renal Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02578082) |
| August 7, 2015 | NCT02518139 | A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | Mylan Inc. | Phase 3 | Completed | Chronic Obstructive Pulmonary Disease (COPD) | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02518139) |
| July 31, 2015 | NCT02512510 | Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) | Mylan Inc. | Phase 3 | Completed | Chronic Obstructive Pulmonary Disease (COPD) | 611 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02512510) |
| June 24, 2015 | NCT02479646 | Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta | Mylan Inc. | Phase 1 | Completed | Healthy Volunteers | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02479646) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 7 |
| Phase 2 | 6 |
| Phase 3 | 15 |
| Phase 4 | 2 |
| Not applicable | 2 |
| Observational | 11 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 42 |
| Terminated | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pulmonary Disease, Chronic Obstructive | 10 |
| Diabetes Mellitus, Type 1 | 4 |
| Pain | 3 |
| Breast Neoplasms | 2 |
| Dermatitis, Atopic | 2 |
| Cystic Fibrosis | 2 |
| Exocrine Pancreatic Insufficiency | 2 |
| Pancreatic Diseases | 2 |
| Digestive System Diseases | 2 |
| Rhinitis, Allergic | 1 |
| Varicose Ulcer | 1 |
| Chemotherapy-Induced Febrile Neutropenia | 1 |
| Neutropenia | 1 |
| Psoriasis | 1 |
| Arthritis, Psoriatic | 1 |
| Bronchitis, Chronic | 1 |
| Emphysema | 1 |
| Pain, Postoperative | 1 |
| Acute Pain | 1 |
| Scabies | 1 |
| Parasitic Diseases | 1 |
| Burns | 1 |
| Hypercholesterolemia | 1 |
| Mycobacterium Infections, Nontuberculous | 1 |
| Thromboembolism | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
- [Real estate law firms in the United States](https://specstream.ai/data/businesses/real-estate-law-firms/united-states)
- [Dumpster rental companies in the United States](https://specstream.ai/data/businesses/dumpster-rental-companies/united-states)
- [Sheet metal fabricators in the United States](https://specstream.ai/data/businesses/sheet-metal-fabricators/united-states)
- [Escrow companies in the United States](https://specstream.ai/data/businesses/escrow-companies/united-states)
- [Structural engineering firms in the United States](https://specstream.ai/data/businesses/structural-engineering-firms/united-states)
